High levels of lipid peroxidation induced by Lipofundin administration correlate with atherosclerotic lesions in rabbits

Pharmacologyonline

Volumn 3, Issue , 2010, Pages 727-736

  Roche, Livan Delgado ^a   Medina, Emilio Acosta ^a   Hernández Matos, Yanet ^a   Bécquer Viart, María A ^a   Vázquez López, Ana M ^b   Fernández Sánchez, Eduardo ^a  

^a UNIVERSITY OF HAVANA   (Cuba)

^b CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

Author keywords

Atherosclerosis; Lipid peroxidation; Lipofundin 20

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; EOSIN; HEMATOXYLIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROPEROXIDE; LIPOFUNDIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; HISTOPATHOLOGY; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RABBIT; SPECTROPHOTOMETRY;

EID: 78650741598     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Witztum JL, Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-92.
2. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000; 28: 1815-26.
3. Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 2007; 380: 50-8.
4. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13: 341-90.
5. Galle J, Hansen-Hagge T, Wanner C, Seibold S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 2006; 185: 219-26.
6. Hailer S, Wolfram G. Influence of artificial fat emulsions on the composition of serum lipoproteins in humans. Am J Clin Nutr 1986; 43: 225-33.
7. Jellinek H, Harsing J, Fuzcesi S. A new model for arteriosclerosis. An electron microscopy study of the lesions induced by i.v. administered fat. Atherosclerosis 1982; 43: 7-18.
8. Noa M, Mas R. Ateromixol y lesion ateroesclerotica en Conejos inducida por Lipofundin. Prog Cien Med 1992; 6:14-19.
9. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-21.
10. Erdelmeier I, Gerard-Monnier D, Yadan JC, Chaudiere J. Reactions of N-methyl-2- phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation. Chem Res Toxicol 1998; 11: 1184-94.
11. Ozdemirler G, Mehmetcik G, Oztezcan S, Toker G, Sivas A, Uysal M. Peroxidation potential and antioxidant activity of serum in patients with diabetes mellitus and myocardial infarction. Horm Metab Res 1995; 27: 194-6.
12. Garjani A, Fathiazad F, Zakheri A, Akbari NA, Azarmie Y, Fakhrjoo A, et al. The effect of total extract of Securigera securidaca L seeds on serum lipid profiles, antioxidant status, and vascular function in hypercholesterolemic rats. J Ethnopharmacol 2009; 126: 525-32.
13. Hur SJ, Du M, Nam K, Williamson M, Ahn DU. Effect of dietary fats on blood cholesterol and lipid and the development of atherosclerosis in rabbits. Nutr Res 2005; 25:925-35.
14. Jain KS, Kathiravan MK, Somani RS, Shishoo CJ. The biology and chemistry of hyperlipidemia. Bioorg Med Chem 2007; 15: 4674-99.
15. Hallberg D. Elimination of exogenous lipids from the bloods stream. An experimental methodological and clinical study in dog and man. Acta Physiol Scand 1965; 65: 1-22.
16. Rifkind BM, Segal P. Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia. JAMA 1983; 250: 1869-72.
17. Carlson LA. Studies on the fat emulsion IntralipidR. I. Association of serum proteins to IntralipidR triglycerides particles. Scand J Clin Lab Invest 1980; 40: 139-40.
18. Wetterau JR, Zilversmit DB. Purification and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes. Chem Phys Lipids 1985; 38: 205-22.
19. Hailer S, Wolfram G, Zoller N. Changes in serum lipoproteins in humans following the infusion of a fat emulsion containing medium and long-chain triglycerides. Eur J Clin Invest 1987; 17:402-7.
20. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009; 47:469-84.
21. Gershman R, Gilbert DL, Nye SW, Dwyer P, Fenn WO. Oxygen poisoning and Xirradiation: mechanisms in common. Science 1954; 119: 623-6.
22. Porter NA. Mechanisms for the autooxidation of polyunsaturated lipids. Acc Chem Res 1986; 19: 262-8.
23. Greenberg ME, Li XM, Gugiu BG, Gu X, Qin J, Salomon RG, et al. The lipid whisker model of the structure of oxidized membranes. J Biol Chem 2008; 283: 2385-96.
24. Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Fuji T, et al. Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary spastic angina: implication of acute coronary events. Int J Cardiol 2009; 135:202-6.
25. Leonarduzzi G, Chiarpotto E, Biasi F, Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res 2005; 49: 1044-9.
26. Limon-Pacheco J, Gonsebatt ME. The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mut Res 2009; 174:137-47.
27. Matzuura E, Kabayashi K, Tabuchi M, Lopez LR. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 2006; 45: 466-86.